Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients

NCT03301558 is registered in ClinicalTrials.gov with Prim. Priv. Doz. Dr. Daniel Cejka as lead sponsor.

NCT NCT03301558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03301558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients
Lead sponsor
Prim. Priv. Doz. Dr. Daniel Cejka
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2025
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant; complications